James P. Boylan

Enavate Sciences Gp, Llc

Assets Managed

$351.507M

Holdings

Last Quarter

2026 - Q1

Filed Date

15d ago

Growth Rate

-30.63%(2Q avg: 12.05%)

Sustained Growth

0 quarters

Portfolio positions

This chart displays the top 10 holdings in Enavate Sciences Gp, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 7 positions.

Assets under management

The assets under management (AUM) of Enavate Sciences Gp, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 351.507M in assets, with a quarterly growth rate of -30.63% and a 2-quarter average growth rate of 12.05%. The portfolio is managed by James P. Boylan, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
SION Sionna Therapeutics Inc Recent Activity	28.27%	$99.344M 2.478M shares@ $40.1 avg price
IMNM Immunome Inc Recent Activity Decreased -24.21%	22.49%	$79.034M 3.614M shares@ $21.87 avg price	Decreased -24.21%
ZBIO Zenas Biopharma Inc Recent Activity	21.8%	$76.62M 3.919M shares@ $19.55 avg price
CMPX Compass Therapeutics Inc Recent Activity	11.73%	$41.199M 7.788M shares@ $5.3 avg price
BBOT Bridgebio Oncology Therapeut Recent Activity	6.69%	$23.511M 2.627M shares@ $8.96 avg price
UPB Upstream Bio Inc Recent Activity	6.3%	$22.137M 2.46M shares@ $9.0 avg price
CAMP Camp4 Therapeutics Corp Recent Activity Decreased -27.83%	2.75%	$9.662M 2.191M shares@ $4.41 avg price	Decreased -27.83%

1-7 of 7